The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: A retrospective cohort study

BMJ Open

Volumn 3, Issue 12, 2013, Pages

  Jesky, Mark ^a,b   Lambert, Amanda ^c   Burden, A C Felix ^d   Cockwell, Paul ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c BIRMINGHAM CITY COUNCIL   (United Kingdom)

^d SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; AGED; ALBUMINURIA; ARTICLE; BANGLADESH; CARDIOVASCULAR DISEASE; CENTRAL AMERICA; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ETHNIC GROUP; ETHNICITY; FEMALE; GENERAL PRACTICE; GLOMERULUS FILTRATION RATE; HUMAN; INDIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PAKISTAN; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; SOUTH ASIA; UNITED KINGDOM; VERY ELDERLY;

EID: 84890839315     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003458     Document Type: Article

References (57)

1. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
2. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-81.
3. Astor BC, Matsushita K, Gansevoort RT, et al . Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011;79:1331-40.
4. Gansevoort RT, Matsushita K, van der Velde M, et al . Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011;80:93-104.
5. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008;8:117.
6. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47.
7. Peralta CA, Katz R, Deboer I, et al. Racial and ethnic differences in kidney function decline among persons without chronic kidney disease. J Am Soc Nephrol 2011;22:1327-34.
8. Barbour SJ, Er L, Djurdjev O, et al. Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian and South Asian CKD patients. Nephrol Dial Transplant 2010;25:3663-72.
9. Choi AI, Rodriguez RA, Bacchetti P, et al. White/black racial differences in risk of end-stage renal disease and death. Am J Med 2009;122:672-8.
10. Crews DC, Sozio SM, Liu Y, et al. Inflammation and the paradox of racial differences in dialysis survival. J Am Soc Nephrol 2011;22:2279-86.
11. Hallan SI, Matsushita K, Sang Y, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012;308:2349-60.
12. Herzog CA, Asinger RW, Berger AK, et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011;80:572-86.
13. Mahmoodi BK, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 2012;380:1649-61.
14. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.
15. Ford ES. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation 2011;123:1737-44.
16. Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 2013;24:302-8.
17. Bahrami H, Kronmal R, Bluemke DA, et al . Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med 2008;168:2138-45.
18. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ 1991;302:560-4.
19. Cappuccio FP. Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin. J Hum Hypertens 1997;11:571-6.
20. Khan NA, Wang H, Anand S, et al. Ethnicity and sex affect diabetes incidence and outcomes. Diabetes Care 2011;34:96-101.
21. Chaturvedi N, Jarrett J, Morrish N, et al. Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study. BMJ 1996;313:848-52.
22. Shekelle P. New contract for general practitioners. BMJ 2003;326:457-8.
23. Calvert M, Shankar A, McManus RJ, et al. Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ 2009;338:b1870.
24. PEEG, Current Estimates, Population Estimates by Ethnic Group Mid-2002-2008 for Primary Care Organisations (experimental). Secondary PEEG, Current Estimates, Population Estimates by Ethnic Group Mid-2002-2008 for Primary Care Organisations (experimental) 02/03/2009. 2008. http://www.ons.gov. uk/ons/taxonomy/index.html?nscl=Population+Estimates+by+Ethnic+Group
25. National Institute for Health and Clinical Excellence: CG73: Chronic Kidney Disease. Secondary National Institute for Health and Clinical Excellence: CG73: Chronic Kidney Disease 2008. http://www.nice.org.uk/CG73
26. Centre HaSCI. Quality and Outcomes Framework. Secondary Quality and Outcomes Framework. http://www.hscic.gov.uk/qof
27. Saunders CL, Abel GA, El Turabi A, et al. Accuracy of routinely recorded ethnic group information compared with self-reported ethnicity: evidence from the English Cancer Patient Experience survey. BMJ Open 2013;3:pii: e002882.
28. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
29. Index of Multiple Deprivation (IMD) 2007. Secondary Index of Multiple Deprivation (IMD) 2007 26/1/2013 2007. http://data.gov.uk/dataset/index-of- multiple-deprivation-imd-2007
30. Townsend P, Phillimore P, Beattie A. Health and deprivation: inequality and the north . London: Croom Helm, 1988.
31. Jordan H, Roderick P, Martin D. The Index of Multiple Deprivation 2000 and accessibility effects on health. J Epidemiol Community Health 2004;58:250-7.
32. Centre HSCI. Primary Care Mortality Database. Secondary Primary Care Mortality Database. http://www.hscic.gov.uk/pcmdatabase
33. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011;80:17-28.
34. Abbasi A, Peelen LM, Corpeleijn E, et al. Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ 2012;345:e5900.
35. Smith S, Waterall J, Burden AC. An evaluation of the performance of the NHS Health Check programme in identifying people at high risk of developing type 2 diabetes. BMJ Open 2013;3:pii: e002219.
36. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
37. Khunti K, Morris DH, Weston CL, et al. Joint prevalence of diabetes, impaired glucose regulation, cardiovascular disease risk and chronic kidney disease in South Asians and White Europeans. PLoS ONE 2013;8:e55580.
38. Carey IM, Shah SM, Harris T, et al. A new simple primary care morbidity score predicted mortality and better explains between practice variations than the Charlson index. J Clin Epidemiol 2013;66:436-44.
39. Johnson-Lawrence V, Kaplan G, Galea S. Socioeconomic mobility in adulthood and cardiovascular disease mortality. Ann Epidemiol 2013;23:167-71.
40. Lazzarino AI, Hamer M, Stamatakis E, et al. The combined association of psychological distress and socioeconomic status with all-cause mortality: a national cohort study. JAMA Intern Med 2013;173:22-7.
41. Jackson CA, Jones NR, Walker JJ, et al. Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia 2012;55:2938-45.
42. Gallo V, Mackenbach JP, Ezzati M, et al. Social inequalities and mortality in Europe - results from a large multi-national cohort. PLoS ONE 2012;7:e39013.
43. Levene LS, Bankart J, Khunti K, et al. Association of primary care characteristics with variations in mortality rates in England: an observational study. PLoS ONE 2012;7:e47800.
44. Adams J, White M. Removing the health domain from the Index of Multiple Deprivation 2004 - effect on measured inequalities in census measure of health. J Public Health (Oxf) 2006;28:379-83.
45. Conley J, Tonelli M, Quan H, et al. Association between GFR, proteinuria, and adverse outcomes among white, Chinese, and South Asian individuals in Canada. Am J Kidney Dis 2012;59:390-9.
46. Buckalew VM Jr, Freedman BI. Reappraisal of the impact of race on survival in patients on dialysis. Am J Kidney Dis 2010;55:1102-10.
47. Raleigh VS. Collection of data on ethnic origin in England. BMJ 2008;337:a1107.
48. Lambert AM, Burden AC, Chambers J, et al. Cardiovascular screening for men at high risk in Heart of Birmingham Teaching Primary Care Trust: the 'Deadly Trio' programme. J Public Health (Oxf) 2012;34:73-82.
49. Humphreys J, Harvey G, Coleiro M, et al. A collaborative project to improve identification and management of patients with chronic kidney disease in a primary care setting in Greater Manchester. BMJ Qual Saf 2012;21:700-8.
50. Martin D, Wright JA. Disease prevalence in the English population: a comparison of primary care registers and prevalence models. Soc Sci Med 2009;68:266-74.
51. Doran T, Fullwood C, Reeves D, et al. Exclusion of patients from pay-for-performance targets by English physicians. N Engl J Med 2008;359:274-84.
52. Campbell S, Hannon K, Lester H. Exception reporting in the Quality and Outcomes Framework: views of practice staff - a qualitative study. Br J Gen Pract 2011;61:183-9.
53. de Lusignan S, Nitsch D, Belsey J, et al. Disparities in testing for renal function in UK primary care: cross-sectional study. Fam Pract 2012;28:638-46.
54. Delanaye P, Cavalier E, Mariat C, et al . Estimating glomerular filtration rate in Asian subjects: where do we stand? Kidney Int 2011;80:439-40.
55. Delanaye P, Mariat C, Maillard N, et al. Are the creatinine-based equations accurate to estimate glomerular filtration rate in African American populations? Clin J Am Soc Nephrol 2011;6:906-12.
56. Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012;307:1941-51.
57. Teo BW, Xu H, Wang D, et al. Estimating glomerular filtration rates by use of both cystatin C and standardized serum creatinine avoids ethnicity coefficients in Asian patients with chronic kidney disease. Clin Chem 2012;58:450-7.